Skip to main content
Top
Published in: BMC Primary Care 1/2013

Open Access 01-12-2013 | Research article

Factors influencing insulin acceptance among type 2 diabetes mellitus patients in a primary care clinic: a qualitative exploration

Authors: Hasliza Abu Hassan, Hizlinda Tohid, Rahmah Mohd Amin, Mohamed Badrulnizam Long Bidin, Leelavathi Muthupalaniappen, Khairani Omar

Published in: BMC Primary Care | Issue 1/2013

Login to get access

Abstract

Background

Many Type 2 Diabetes Mellitus (T2DM) patients refuse insulin therapy even when they require this modality of treatment. However, some eventually accept insulin. This study aimed to explore the T2DM patients’ reasons for accepting insulin therapy and their initial barriers to use insulin.

Methods

This qualitative study interviewed twenty-one T2DM patients at a primary care clinic who had been on insulin for more than a year through three in-depth interviews and three focus group discussions. A semi structured interview protocol was used and the sessions were audio-recorded. Subsequently, thematic analysis was conducted to identify major themes.

Results

The participants’ acceptance of insulin was influenced by their concerns and beliefs about diabetes and insulin. Concerns about complications of poorly controlled diabetes and side effects of other treatment regime had resulted in insulin acceptance among the participants. They also had a strong belief in insulin benefits and effectiveness. These concerns and beliefs were the results of having good knowledge about the diabetes and insulin, experiential learning, as well as doctors’ practical and emotional support that helped them to accept insulin therapy and become efficient in self-care management. These factors also allayed their negative concerns and beliefs towards diabetes and insulin, which were their barriers for insulin acceptance as it caused fear to use insulin. These negative concerns were related to injection (self-injection, needle phobia, injection pain), and insulin use (inconvenience, embarrassment, lifestyle restriction, negative social stigma, and poor self-efficacy), whereas the negative beliefs were 'insulin could cause organ damage’, 'their diabetes was not serious enough’, 'insulin is for life-long’, and 'insulin is for more severe disease only’.

Conclusions

Exploring patients’ concerns and beliefs about diabetes and insulin is crucial to assist physicians in delivering patient-centered care. By understanding this, physicians could address their concerns with aim to modify their patients’ misconceptions towards insulin therapy. In addition, continuous educations as well as practical and emotional support from others were found to be valuable for insulin acceptance.

Trial registration

Universiti Kebangsaan Malaysia FF-214-2009.
Literature
1.
go back to reference Westphal SA, Palumbo PJ: A case for introducing insulin early in the treatment of type 2 diabetes mellitus. Insulin. 2006, 1: 65-69. 10.1016/S1557-0843(06)80012-6.CrossRef Westphal SA, Palumbo PJ: A case for introducing insulin early in the treatment of type 2 diabetes mellitus. Insulin. 2006, 1: 65-69. 10.1016/S1557-0843(06)80012-6.CrossRef
2.
go back to reference Vinik A: Advancing therapy in type 2 diabetes mellitus with early, comprehensive progression from oral agents to insulin therapy. Clin Ther. 2007, 29: 1236-1253. 10.1016/j.clinthera.2007.07.005.CrossRef Vinik A: Advancing therapy in type 2 diabetes mellitus with early, comprehensive progression from oral agents to insulin therapy. Clin Ther. 2007, 29: 1236-1253. 10.1016/j.clinthera.2007.07.005.CrossRef
3.
go back to reference Goodall G, Sarpong EM, Hayes C, Valentine WJ: The consequences of delaying insulin initiation in UK type 2 diabetes patients failing oral hyperglycaemic agents: a modeling study. BMC Endocr Disord. 2009, 9: 19-10.1186/1472-6823-9-19.CrossRefPubMedPubMedCentral Goodall G, Sarpong EM, Hayes C, Valentine WJ: The consequences of delaying insulin initiation in UK type 2 diabetes patients failing oral hyperglycaemic agents: a modeling study. BMC Endocr Disord. 2009, 9: 19-10.1186/1472-6823-9-19.CrossRefPubMedPubMedCentral
4.
go back to reference Rubino A, McQuay LJ, Gough SC, Kvasz M, Tennis P: Delayed initiation of subcutaneous insulin therapy after failure of oral glucose-lowering agents in patients with type 2 diabetes: a population-based analysis in the UK. Diabet Med. 2007, 24: 1412-1418. 10.1111/j.1464-5491.2007.02279.x.CrossRefPubMed Rubino A, McQuay LJ, Gough SC, Kvasz M, Tennis P: Delayed initiation of subcutaneous insulin therapy after failure of oral glucose-lowering agents in patients with type 2 diabetes: a population-based analysis in the UK. Diabet Med. 2007, 24: 1412-1418. 10.1111/j.1464-5491.2007.02279.x.CrossRefPubMed
5.
go back to reference Nichols GA, Koo YH, Shah SN: Delay of insulin addition to oral combination therapy despite inadequate glycemic control: delay of insulin therapy. J Gen Intern Med. 2007, 22: 453-458. 10.1007/s11606-007-0139-y.CrossRefPubMedPubMedCentral Nichols GA, Koo YH, Shah SN: Delay of insulin addition to oral combination therapy despite inadequate glycemic control: delay of insulin therapy. J Gen Intern Med. 2007, 22: 453-458. 10.1007/s11606-007-0139-y.CrossRefPubMedPubMedCentral
6.
go back to reference Kruger D, Spollett G: Addressing barriers to timely intensification of diabetes care: the relationship between clinical inertia and patient behaviour. Consultant. 2009, 49 (7): S20-S25. Kruger D, Spollett G: Addressing barriers to timely intensification of diabetes care: the relationship between clinical inertia and patient behaviour. Consultant. 2009, 49 (7): S20-S25.
7.
go back to reference Peyrot M, Rubin RR, Khunti K: Addressing barriers to initiation of insulin in patients with type 2 diabetes. Prim Care Diabetes. 2010, 4 (1): S11-S18.CrossRefPubMed Peyrot M, Rubin RR, Khunti K: Addressing barriers to initiation of insulin in patients with type 2 diabetes. Prim Care Diabetes. 2010, 4 (1): S11-S18.CrossRefPubMed
8.
go back to reference Lee YK, Lee PY, Ng CJ: A qualitative study on healthcare professionals’ perceived barriers to insulin initiation in a multi-ethnic population. BMC Fam Pract. 2012, 13: 28-10.1186/1471-2296-13-28.CrossRefPubMedPubMedCentral Lee YK, Lee PY, Ng CJ: A qualitative study on healthcare professionals’ perceived barriers to insulin initiation in a multi-ethnic population. BMC Fam Pract. 2012, 13: 28-10.1186/1471-2296-13-28.CrossRefPubMedPubMedCentral
9.
go back to reference Brod M, Kongsø JH, Lessard S, Christensen TL: Psychological insulin resistance: patient beliefs and implications for diabetes management. Qual Life Res. 2009, 18: 23-32. 10.1007/s11136-008-9419-1.CrossRefPubMed Brod M, Kongsø JH, Lessard S, Christensen TL: Psychological insulin resistance: patient beliefs and implications for diabetes management. Qual Life Res. 2009, 18: 23-32. 10.1007/s11136-008-9419-1.CrossRefPubMed
10.
go back to reference Gherman A, Veresiu IA, Sassu RA, Schnur JB, Scheckner BL, Montgomery GH: Psychological insulin resistance: a critical review of the literature. Practical Diabetes Int. 2011, 28 (3): 125-128. 10.1002/pdi.1574.CrossRef Gherman A, Veresiu IA, Sassu RA, Schnur JB, Scheckner BL, Montgomery GH: Psychological insulin resistance: a critical review of the literature. Practical Diabetes Int. 2011, 28 (3): 125-128. 10.1002/pdi.1574.CrossRef
11.
go back to reference United Kingdom Prospective Diabetes Study Group: United Kingdom prospective diabetes study (UKPDS) 13: relative efficacy of randomly allocated diet, sulphonylurea, insulin, or metformin in patients with newly diagnosed non-insulin dependent diabetes followed for three years. BMJ. 1995, 310: 83-88.CrossRef United Kingdom Prospective Diabetes Study Group: United Kingdom prospective diabetes study (UKPDS) 13: relative efficacy of randomly allocated diet, sulphonylurea, insulin, or metformin in patients with newly diagnosed non-insulin dependent diabetes followed for three years. BMJ. 1995, 310: 83-88.CrossRef
12.
go back to reference Polonsky WH, Fisher L, Guzman S, Villa-Caballero L, Edelman SV: Psychological insulin resistance in patients with type 2 diabetes : the scope of the problem. Diabetes Care. 2005, 28: 2543-2545. 10.2337/diacare.28.10.2543.CrossRefPubMed Polonsky WH, Fisher L, Guzman S, Villa-Caballero L, Edelman SV: Psychological insulin resistance in patients with type 2 diabetes : the scope of the problem. Diabetes Care. 2005, 28: 2543-2545. 10.2337/diacare.28.10.2543.CrossRefPubMed
13.
go back to reference Larkin ME, Capasso VA, Chen CL, Mahoney EK, Hazard B, Cagliero E, et al: Measuring psychological insulin resistance: barriers to insulin use. Diabetes Educ. 2008, 34: 511-517. 10.1177/0145721708317869.CrossRefPubMed Larkin ME, Capasso VA, Chen CL, Mahoney EK, Hazard B, Cagliero E, et al: Measuring psychological insulin resistance: barriers to insulin use. Diabetes Educ. 2008, 34: 511-517. 10.1177/0145721708317869.CrossRefPubMed
14.
go back to reference Woudenberg YJC, Lucas C, Latour C, Scholte op Reimer WJM: Acceptance of insulin therapy: a long shot? Psychological insulin resistance in primary care. Diabet Med. 2012, 29 (6): 796-802. 10.1111/j.1464-5491.2011.03552.x.CrossRefPubMed Woudenberg YJC, Lucas C, Latour C, Scholte op Reimer WJM: Acceptance of insulin therapy: a long shot? Psychological insulin resistance in primary care. Diabet Med. 2012, 29 (6): 796-802. 10.1111/j.1464-5491.2011.03552.x.CrossRefPubMed
15.
go back to reference Nur Azmiah Z, Zulkarnain AK, Tahir A: Psychological insulin resistance (PIR) among type 2 diabetes patients at public health clinics in federal territory of Malaysia. Int Med J Malaysia. 2011, 10 (2): 7-12. Nur Azmiah Z, Zulkarnain AK, Tahir A: Psychological insulin resistance (PIR) among type 2 diabetes patients at public health clinics in federal territory of Malaysia. Int Med J Malaysia. 2011, 10 (2): 7-12.
16.
go back to reference Wong S, Lee J, Kot Y, Chong MF, Lam CK, Tang WE: Perceptions of insulin therapy amongst Asian patients with diabetes in Singapore. Diabetes Medicine. 2011, 28: 206-211. 10.1111/j.1464-5491.2010.03195.x.CrossRef Wong S, Lee J, Kot Y, Chong MF, Lam CK, Tang WE: Perceptions of insulin therapy amongst Asian patients with diabetes in Singapore. Diabetes Medicine. 2011, 28: 206-211. 10.1111/j.1464-5491.2010.03195.x.CrossRef
17.
go back to reference Peyrot M, Rubin RR, Lauritzen T, Skovlund SE, Snoek FJ, Matthews DR, et al: Resistance to insulin therapy among patients and providers: results of the cross-national diabetes attitudes, wishes and needs (DAWN) study. Diabetes Care. 2005, 28: 2673-2679. 10.2337/diacare.28.11.2673.CrossRefPubMed Peyrot M, Rubin RR, Lauritzen T, Skovlund SE, Snoek FJ, Matthews DR, et al: Resistance to insulin therapy among patients and providers: results of the cross-national diabetes attitudes, wishes and needs (DAWN) study. Diabetes Care. 2005, 28: 2673-2679. 10.2337/diacare.28.11.2673.CrossRefPubMed
18.
go back to reference Karter AJ, Subramanian U, Saha C, Crosson JC, Parker MM, Swain BE, et al: Barriers to insulin initiation: the translating research into action for diabetes insulin starts project. Diabetes Care. 2010, 33 (4): 733-735. 10.2337/dc09-1184.CrossRefPubMedPubMedCentral Karter AJ, Subramanian U, Saha C, Crosson JC, Parker MM, Swain BE, et al: Barriers to insulin initiation: the translating research into action for diabetes insulin starts project. Diabetes Care. 2010, 33 (4): 733-735. 10.2337/dc09-1184.CrossRefPubMedPubMedCentral
19.
go back to reference Bogatrean MP, Hâncu N: People with type 2 diabetes facing the reality of starting insulin therapy: factors involved in psychological insulin resistance. Practical Diabetes International. 2004, 21 (7): 247-252. 10.1002/pdi.670.CrossRef Bogatrean MP, Hâncu N: People with type 2 diabetes facing the reality of starting insulin therapy: factors involved in psychological insulin resistance. Practical Diabetes International. 2004, 21 (7): 247-252. 10.1002/pdi.670.CrossRef
20.
go back to reference Polonsky WH, Jackson RA: What’s so tough about taking insulin? Addressing the problem of psychological insulin resistance in type 2 diabetes. Clinical Diabetes. 2004, 22: 147-150. 10.2337/diaclin.22.3.147.CrossRef Polonsky WH, Jackson RA: What’s so tough about taking insulin? Addressing the problem of psychological insulin resistance in type 2 diabetes. Clinical Diabetes. 2004, 22: 147-150. 10.2337/diaclin.22.3.147.CrossRef
21.
go back to reference Shiu AT, Kwan JJ, Wong RY: Social stigma as a barrier to diabetes self-management: implications for multi-level interventions. J Clin Nurs. 2003, 12 (1): 149-150. 10.1046/j.1365-2702.2003.00735.x.CrossRef Shiu AT, Kwan JJ, Wong RY: Social stigma as a barrier to diabetes self-management: implications for multi-level interventions. J Clin Nurs. 2003, 12 (1): 149-150. 10.1046/j.1365-2702.2003.00735.x.CrossRef
22.
go back to reference Hunt LM, Valenzuela MA, Pugh JA: NIDDM patients’ fears and hopes about insulin therapy. The basis of patient reluctance. Diabetes Care. 1997, 20 (3): 292-298. 10.2337/diacare.20.3.292.CrossRefPubMed Hunt LM, Valenzuela MA, Pugh JA: NIDDM patients’ fears and hopes about insulin therapy. The basis of patient reluctance. Diabetes Care. 1997, 20 (3): 292-298. 10.2337/diacare.20.3.292.CrossRefPubMed
23.
go back to reference Nam S, Chesla C, Stotts NA, Kroon L, Janson SL: Factors associated with psychological insulin resistance in individuals with type 2 diabetes. Diabetes Care. 2010, 33 (8): 1747-1749. 10.2337/dc10-0099.CrossRefPubMedPubMedCentral Nam S, Chesla C, Stotts NA, Kroon L, Janson SL: Factors associated with psychological insulin resistance in individuals with type 2 diabetes. Diabetes Care. 2010, 33 (8): 1747-1749. 10.2337/dc10-0099.CrossRefPubMedPubMedCentral
24.
go back to reference Morris JE, Povey RC, Street CG: Experiences of people with type 2 diabetes who have changed from oral medication to self-administered insulin injections. Pract Diabetes Int. 2005, 22 (7): 239-243. 10.1002/pdi.829.CrossRef Morris JE, Povey RC, Street CG: Experiences of people with type 2 diabetes who have changed from oral medication to self-administered insulin injections. Pract Diabetes Int. 2005, 22 (7): 239-243. 10.1002/pdi.829.CrossRef
25.
go back to reference Guimarães C, Marra CA, Gill S, Meneilly G, Simpson S, Godoy ALPC, et al: Exploring patients’ perceptions for insulin therapy in type 2 diabetes: a Brazilian and Canadian qualitative study. Patient Prefer Adherence. 2010, 4: 171-179.CrossRefPubMedPubMedCentral Guimarães C, Marra CA, Gill S, Meneilly G, Simpson S, Godoy ALPC, et al: Exploring patients’ perceptions for insulin therapy in type 2 diabetes: a Brazilian and Canadian qualitative study. Patient Prefer Adherence. 2010, 4: 171-179.CrossRefPubMedPubMedCentral
26.
go back to reference Nair KM, Levine MAH, Lohfeld LH, Gerstein HC: “I take what I think works for me”: a qualitative study to explore patient perception of diabetes treatment benefits and risks. Can J Clin Pharmacol. 2007, 14 (2): e251-e259.PubMed Nair KM, Levine MAH, Lohfeld LH, Gerstein HC: “I take what I think works for me”: a qualitative study to explore patient perception of diabetes treatment benefits and risks. Can J Clin Pharmacol. 2007, 14 (2): e251-e259.PubMed
27.
go back to reference Phillips A: Experiences of patients with type 2 diabetes starting insulin therapy. Nurs Stand. 2007, 21 (22): 35-41. 10.7748/ns2007.02.21.22.35.c4515.CrossRef Phillips A: Experiences of patients with type 2 diabetes starting insulin therapy. Nurs Stand. 2007, 21 (22): 35-41. 10.7748/ns2007.02.21.22.35.c4515.CrossRef
28.
go back to reference Merriam SB: Qualitative research: a guide to design and implementation – revised and expanded from qualitative research and case study applications in education. 2009, San Francisco: Jossey-Bass Merriam SB: Qualitative research: a guide to design and implementation – revised and expanded from qualitative research and case study applications in education. 2009, San Francisco: Jossey-Bass
29.
go back to reference Robinson N: The use of focus group methodology - with selected examples from sexual health research. J Adv Nurs. 1999, 29 (4): 90-5913.CrossRef Robinson N: The use of focus group methodology - with selected examples from sexual health research. J Adv Nurs. 1999, 29 (4): 90-5913.CrossRef
30.
go back to reference Cefalu WT, Mathieu C, Pandson J, Freemantle N, Gough S, Canovatchel W: Patients’ Perceptions of subcutaneous insulin in the OPTIMIZE study: a multicenter follow-up study. Diabetes Technol Ther. 2008, 10 (1): 25-38. 10.1089/dia.2008.0249.CrossRefPubMed Cefalu WT, Mathieu C, Pandson J, Freemantle N, Gough S, Canovatchel W: Patients’ Perceptions of subcutaneous insulin in the OPTIMIZE study: a multicenter follow-up study. Diabetes Technol Ther. 2008, 10 (1): 25-38. 10.1089/dia.2008.0249.CrossRefPubMed
31.
go back to reference Snoek F, Skovlund SE, Pouwer F: Development and validation of the insulin treatment appraisal scale (ITAS) in patients with type 2 diabetes. BMC Health Qual Life Outcomes. 2007, 5: 69-10.1186/1477-7525-5-69.CrossRef Snoek F, Skovlund SE, Pouwer F: Development and validation of the insulin treatment appraisal scale (ITAS) in patients with type 2 diabetes. BMC Health Qual Life Outcomes. 2007, 5: 69-10.1186/1477-7525-5-69.CrossRef
32.
go back to reference Korytkowski M, Bell D, Jacobsen C, Suwannasari R: A multicenter, randomized, open-label, comparative, two-period cross over trial of preference, efficacy, and safety profiles of a prefilled, disposable pen and conventional vial/syringe for insulin injection in patients with type 1 or 2 diabetes mellitus. Clin Ther. 2003, 25: 2836-2848. 10.1016/S0149-2918(03)80337-5.CrossRefPubMed Korytkowski M, Bell D, Jacobsen C, Suwannasari R: A multicenter, randomized, open-label, comparative, two-period cross over trial of preference, efficacy, and safety profiles of a prefilled, disposable pen and conventional vial/syringe for insulin injection in patients with type 1 or 2 diabetes mellitus. Clin Ther. 2003, 25: 2836-2848. 10.1016/S0149-2918(03)80337-5.CrossRefPubMed
33.
go back to reference Rakel RE: Improving patient acceptance and adherence in diabetes management: a focus on insulin therapy. Adv Ther. 2009, 26 (9): 838-846. 10.1007/s12325-009-0061-2.CrossRefPubMed Rakel RE: Improving patient acceptance and adherence in diabetes management: a focus on insulin therapy. Adv Ther. 2009, 26 (9): 838-846. 10.1007/s12325-009-0061-2.CrossRefPubMed
34.
go back to reference Graff MR, McClanahan MA: Assessment by patients with diabetes mellitus of two insulin pen delivery systems versus a vial and syringe. Clin Ther. 1998, 20: 486-496. 10.1016/S0149-2918(98)80058-1.CrossRefPubMed Graff MR, McClanahan MA: Assessment by patients with diabetes mellitus of two insulin pen delivery systems versus a vial and syringe. Clin Ther. 1998, 20: 486-496. 10.1016/S0149-2918(98)80058-1.CrossRefPubMed
35.
go back to reference Korytkowski M, Niskanen L, Asakura T: FlexPen: addressing issues of confidence and convenience in insulin delivery. Clin Ther. 2005, 27 (Suppl. B): S89-S100.CrossRefPubMed Korytkowski M, Niskanen L, Asakura T: FlexPen: addressing issues of confidence and convenience in insulin delivery. Clin Ther. 2005, 27 (Suppl. B): S89-S100.CrossRefPubMed
36.
go back to reference Brunton S: Insulin delivery systems: reducing barriers to insulin therapy and advancing diabetes mellitus treatment. Am J Med. 2008, 121: S35-S41. 10.1016/j.amjmed.2008.03.025.CrossRefPubMed Brunton S: Insulin delivery systems: reducing barriers to insulin therapy and advancing diabetes mellitus treatment. Am J Med. 2008, 121: S35-S41. 10.1016/j.amjmed.2008.03.025.CrossRefPubMed
37.
go back to reference Guimarães C, Marra CA, Gill S, Simpson S, Meneilly G, Queiroz RHC, et al: A discrete choice experiment evaluation of patients’ preferences for different risk, benefit, and delivery attributes of insulin therapy for diabetes management. Patient Prefer Adherence. 2010, 4: 433-440.CrossRefPubMedPubMedCentral Guimarães C, Marra CA, Gill S, Simpson S, Meneilly G, Queiroz RHC, et al: A discrete choice experiment evaluation of patients’ preferences for different risk, benefit, and delivery attributes of insulin therapy for diabetes management. Patient Prefer Adherence. 2010, 4: 433-440.CrossRefPubMedPubMedCentral
38.
go back to reference Funnell MM: Quality of life and insulin therapy in type 2 diabetes mellitus. Insulin. 2008, 3 (1): 31-36. 10.1016/S1557-0843(08)80009-7.CrossRef Funnell MM: Quality of life and insulin therapy in type 2 diabetes mellitus. Insulin. 2008, 3 (1): 31-36. 10.1016/S1557-0843(08)80009-7.CrossRef
39.
go back to reference Janz NK, Champion VL, Strecher J: The health belief model. Health behavior and health education: theory, research and practice. Edited by: Glanz K, Rimer BK, Lewis FM. 2002, San Fransisco: Jossey-Bass, 45-66. 3 Janz NK, Champion VL, Strecher J: The health belief model. Health behavior and health education: theory, research and practice. Edited by: Glanz K, Rimer BK, Lewis FM. 2002, San Fransisco: Jossey-Bass, 45-66. 3
40.
go back to reference Mohd Ali S, Jusoff K: Barriers to optimal control of type 2 diabetes in Malaysian Malay patients. Glob J Health Sci. 2009, 1 (2): 106-118. Mohd Ali S, Jusoff K: Barriers to optimal control of type 2 diabetes in Malaysian Malay patients. Glob J Health Sci. 2009, 1 (2): 106-118.
41.
go back to reference Kunt T, Snoek FJ: Barriers to insulin initiation and intensification and how to overcome them. Int J Clin Pract. 2009, 63 (Suppl. 164): 6-10.CrossRef Kunt T, Snoek FJ: Barriers to insulin initiation and intensification and how to overcome them. Int J Clin Pract. 2009, 63 (Suppl. 164): 6-10.CrossRef
42.
go back to reference Küstner E: How to convince people with the 2 diabetes to start with insulin? Treatment options for patients with psychological insulin resistance. MMW Fortschr Med. 2008, 150: 49-52.CrossRef Küstner E: How to convince people with the 2 diabetes to start with insulin? Treatment options for patients with psychological insulin resistance. MMW Fortschr Med. 2008, 150: 49-52.CrossRef
43.
go back to reference Rubin RR, Peyrot M, Siminerio LM: Health care and patient-reported outcomes – results of the cross-national diabetes attitudes, wishes and needs (DAWN) study. Diabetes Care. 2006, 29: 1249-1255. 10.2337/dc05-2494.CrossRefPubMed Rubin RR, Peyrot M, Siminerio LM: Health care and patient-reported outcomes – results of the cross-national diabetes attitudes, wishes and needs (DAWN) study. Diabetes Care. 2006, 29: 1249-1255. 10.2337/dc05-2494.CrossRefPubMed
Metadata
Title
Factors influencing insulin acceptance among type 2 diabetes mellitus patients in a primary care clinic: a qualitative exploration
Authors
Hasliza Abu Hassan
Hizlinda Tohid
Rahmah Mohd Amin
Mohamed Badrulnizam Long Bidin
Leelavathi Muthupalaniappen
Khairani Omar
Publication date
01-12-2013
Publisher
BioMed Central
Published in
BMC Primary Care / Issue 1/2013
Electronic ISSN: 2731-4553
DOI
https://doi.org/10.1186/1471-2296-14-164

Other articles of this Issue 1/2013

BMC Primary Care 1/2013 Go to the issue